The chemical industry is back in business after being stuck in limbo for a spell, making it an attractive investment proposition. The industry’s upturn is expected to continue this year on continued momentum across major end-markets.
Despite a few industry-related headwinds -- weak demand across agricultural and energy markets and sluggishness in China -- there are a number of reasons to be optimistic about the broader chemical industry for both the short and long haul. Let’s find out what’s supporting the bullish case for chemical stocks.
Shale Bounty – Driving Force for Chemical Spending
The shale gas revolution in the U.S. has been a huge driving force behind chemical investment on plants and equipment in the country. According to the American Chemistry Council (“ACC”), the U.S. has emerged as an attractive investment location and petrochemical makers are now significantly expanding capacity in the country, leveraging new supplies of natural gas. New methods of extraction such as horizontal drilling and hydraulic fracturing (or fracking) are boosting shale production, bringing down prices of ethane (derived from shale gas) in the process.
The shale boom has incentivized a number of chemical companies to pump in billions of dollars for setting up facilities (crackers) in the U.S. to produce ethylene and propylene in a cost-effective way. Per the ACC, 310 new chemical projects have been already announced by chemical makers worth around $185 billion that are under construction or planned. Such investments -- many backed by Federal government support -- are expected to boost capacity and export over the next several years.
Rebound in Construction
A recovery across housing and commercial construction -- major chemical end-markets -- has been another supporting factor for the chemical industry recovery. After being hit hard in the recession, the construction sector has bounced back on the back of healthy housing fundamentals.
Recent housing data has been fairly upbeat with U.S. housing starts scaling a four-month high in June, buoyed by a rise in both single-family and multi-family construction. Per the Commerce Department, housing starts climbed 8.3% to a seasonally adjusted annualized rate of 1.22 million units in June, the highest level since Feb 2017. Single-family starts rose 6.3% while construction of multi-family homes shot up 13.3%. Building permits, a proxy for future construction, also went up 7.4% for the month. These strong data paint an upbeat picture for U.S. homebuilding moving ahead.
The renewal of long-stalled construction projects and long-awaited access to credit from lending institutions has also helped invigorate the commercial construction sector. U.S. architecture firm billings continue to rise. The US Architecture Billings Index (ABI), an indicator that offers a glimpse into the future of U.S. non-residential construction spending activity, clocked 54.2 in June 2017 (a reading above 50 indicates an increase in billings), up from 53.0 in May. Moreover, the American Institute of Architects (AIA) expects non-residential construction spending to go up 3.8% in 2017 and 3.6% in 2018.
Positives such as an improving economy, steady buyer demand, low unemployment levels, low interest rates and positive consumer confidence raise optimism about the construction sector’s performance.
Healthy Automotive Demand
Chemical makers continue to see healthy demand from the automotive sector -- a major end-use market. The last two years have been exceptional for the auto sector. Sales in the U.S. saw record highs in both years, while sales in China and Europe also gained strength.
U.S. light vehicles (a key end-user market for chemicals) had a strong run in 2016, supported by an improving job market, rising personal income, improved consumer confidence, low fuel prices and attractive financing options. While recent sales trends suggest that the automotive industry has peaked, it is still in good health.
According to IHS Markit, global light vehicle sales are expected to increase 1.5% year over year to 93.5 million units in 2017. Moreover, IHS Markit sees U.S. light vehicle sales to reach 17.4 million units in 2017 -- a slight moderation from the 2016 level of 17.5 million units, but still looks poised for another strong year.
Low interest rates, favorable financing and cheap oil have also backed a recovery in the European auto market. The auto industry in Asian countries, especially China, is also expected to thrive over the next several years. This augurs well for chemical demand in this important end-market.
A Resurgent European Economy
The Eurozone economy has gained traction of late, as evident from recent upbeat economic data that suggest a recovery is steadily firming in the region. The European chemical industry has also swung back to life on the back of a rebounding Eurozone economy.
The Eurozone GDP rose 0.6% in the first quarter of 2017 (according to Eurostat data) on a quarter-over-quarter basis, the fastest pace since 2015 and also above expectations. The Eurozone also outstripped the U.S. when considering the annualized economic growth rate. While the Eurozone economy rose 2.3% on an annualized basis during the first quarter, the U.S. economy expanded 1.2%. The region’s recovery is backed by rising domestic demand, declining unemployment and strengthening business and consumer confidence.
While political risks may remain a drag, the Eurozone economy is poised for a strong 2017. The European Commission, in its spring 2017 forecast, said that it expects the Eurozone to grow 1.7% in 2017 (up from previous estimate of 1.6%), followed by 1.8% in 2018.
Chemical Bonding – M&A Binge Continues
Chemical makers remain actively focused on mergers and acquisitions to diversify and shore up growth. These companies are increasingly looking for cost synergy opportunities and enhanced operational scale through consolidations. The $130 billion mega-merger of Dow Chemical DOW and DuPont DD -- the biggest chemical deal ever -- is a huge testimony to these strategic moves.
Other major deals that have taken place in the chemical space in the recent past include ChemChina’s $43 billion acquisition of Syngenta (SYT - Free Report) , Albemarle Corp.’s (ALB - Free Report) $6.2 billion buyout of Rockwood Holdings, Inc., Merck KGaA's $17 billion acquisition of Sigma-Aldrich, and the $66 billion proposed merger between Monsanto Company (MON - Free Report) and Bayer AG.
Strategic Actions to Reap Benefits
Chemical companies continue to shift their focus on high-growth markets (driven by megatrends) in an effort to cut their exposure on other businesses that are struggling with weak demand and input costs pressure. Moreover, cost-cutting measures -- including plant closures and headcount reduction -- and productivity improvement actions by chemical companies are expected to yield industry-wide margin improvements.
Some chemical makers are also disposing non-core assets as they shift their focus on high-margin businesses. A number of chemical makers are also taking appropriate pricing actions (reflected by hikes in chemical prices in the recent past) in the wake of a sharp rise in raw materials costs. This is also expected to lend support to their margins.
Stocks Worth a Look Right Now
As you can see from the above-mentioned factors, there are many reasons to be optimistic about the chemical industry. Chemical stocks that are well placed in the current operating backdrop include Westlake Chemical Corporation (WLK - Free Report) and The Chemours Company (CC - Free Report) , both sporting a Zacks Rank #1 (Strong Buy), as well as, KMG Chemicals, Inc. (KMG - Free Report) , Celanese Corporation (CE - Free Report) , Quaker Chemical Corporation (KWR - Free Report) and Albemarle Corp., all carrying a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.
Westlake has gained around 54% over a year. The stock has a long-term expected earnings per share (EPS) growth rate of roughly 7.2%. Earnings estimates for the current year have been revised 3% upward over the last 60 days.
Chemours has a long-term expected EPS growth rate of roughly 15.5%. Earnings estimates for the current year have been revised 4.5% upward over the last 60 days. The stock has gained a whopping 410% over the past year.
KMG Chemicals has gained around 89% over a year. The stock’s earnings estimates for the current year have been revised 3% upward over the last 60 days. It has an expected earnings growth of 29.8% for the current year.
Celanese has gained around 40% over the past year. The stock has an expected earnings growth of 10.5% for the current year. It also has a long-term expected EPS growth rate of roughly 8%.
Quaker Chemical has gained around 55% over a year. The stock has an expected earnings growth of around 8% for the current year. It also has a long-term expected EPS growth rate of roughly 8.5%.
Albemarle has gained roughly 37% over a year. The stock has an expected earnings growth of 21.6% for the current year. It also has a long-term expected EPS growth rate of roughly 14.4%.
(Check out our latest Chemical Industry Outlook for a more detailed discussion on the fundamental trends.
More Stock News: Bigger than the iPhone!
It could become the mother of all technological revolutions. Apple sold a mere 1 billion iPhones in 10 years but a new breakthrough is expected to generate more than 27 billion devices in just 3 years, creating a $1.7 trillion market.
Zacks has just released a Special Report that spotlights this fast-emerging phenomenon and 6 tickers for taking advantage of it. If you don't buy now, you may kick yourself in 2020. Click here for the 6 trades >>